Akebia Therapeutics, Inc.
AKBA$0.67−4.69% 1D
$0.771752-week range$3.20
Updated . Prices are snapshots and may be delayed.
Akebia Therapeutics, Inc. price chart
−14.41% over 7D
$0.7994
$0.67
Oct 18
Oct 20
AI Outlook for Akebia Therapeutics, Inc.
Bearish posture- Long-term trend-42.6% vs 200-day average
- Medium-term trend-23.3% vs 50-day average
- Averages50-day below 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Akebia Therapeutics, Inc. performance
1D
−4.7%
7D
−16.4%
30D
−27.0%
90D
−50.0%
1Y
−78.8%
About Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. is a biotechnology company based in the United States, listed on NASDAQ since 2014 (ticker AKBA).
Akebia Therapeutics, Inc. market data
What is the price of Akebia Therapeutics, Inc. today?
Akebia Therapeutics, Inc. (AKBA) is at $0.67, −4.69% on the day.
What is the 52-week range of Akebia Therapeutics, Inc.?
Over the past year Akebia Therapeutics, Inc. has traded between $0.7717 and $3.20. It is currently -4% of the way up that range.
Similar stocks
MRNA
Moderna Inc
$218.01−7.2%
IBRX
Immunitybio Inc
$9.18−8.4%
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.47−15.7%
MDXH
MDxHealth SA
$0.2066−48.4%
SLS
SELLAS Life Sciences Group, Inc.
$9.98−10.9%
IOVA
Iovance Biotherapeutics, Inc.
$13.62−7.0%
PURR
Hyperliquid Strategies Inc.
$9.07−5.6%
CYPH
Cypherpunk Technologies Inc.
$2.57−11.4%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.